结论胃底贲门癌术后腹腔温热灌注化疗，对于防治肿瘤腹膜转移、提高患者生存率有重要意义。
Conclusion Intraperitoneal hyperthermic perfusion chemotherapy in postoperative gastric fundus cardiac carcinoma may be effect on preventing the peritoneal metastasis and improving the survival rate.
胃肠肿瘤术后低渗热灌注腹腔化疗预防腹腔复发的临床疗效。
Clinical Study on prevention of the postoperative gastrointestinal tumors from intraperitoneal relapse by intraperitoneal chemotherapy through hypothermal hypotonic perfusion.
目的研究胃癌术后腹腔热灌注化疗联合静脉化疗的治疗效果。
Objective:To study the effect of intraperitoneal hyperthermic perfusion chemotherapy combined with venoclysis on postoperative gastric cancer.
本文设计了这套智能型全自动腹腔灌注热化疗设备。
In this article is reported an intraperitoneal perfusion machine which is designed for instituting the treatment.
对照组30例单纯采用顺铂使用体腔热灌注机腹腔热灌注化疗。
The control group of 30 patients were simply treated with peritoneal perfusion chemotherapy of cisplatin.
对25例进展期胃肠道恶性肿瘤患者手术前后采用腹腔内热灌注化疗。
Pre-and postoperative perfusion of thermochemotherapy was used in 25 cases of advanced malignant tumors of digestive tract.
目的探讨术中腹腔低渗温热灌注化疗对胃癌患者术后的临床疗效。
Objective To investigate the clinical effect and value of hypotonic intraoperative intraperitoneal chemohyperthermia(HIPCH) in advanced gastric cancer.
目的探讨术中腹腔内温热灌注(IPHP)化疗在中晚期大肠癌中的临床价值。
Objective to determine the clinical value of intraperitoneal hyperthermic perfusion (IPHP) chemotherapy in preventing postoperative recurrence of advanced colorectal cancer.
结论腹腔热灌注化疗能明显提高胃癌术后病人的生存率和生存质量。
Conclusion IPHP with chemotherapeutic agents can improve the survival rate and life quality of postoperative stomach cancer patients.
结论腹腔温热灌注化疗不会对兔造成严重影响，是安全和可行的。
Conclusion Intraperitoneal hyperthermic chemotherapy, resulting in no harm to rabbits, is safe and feasible.
方法：对9例癌性腹水患者给予中心静脉导管作持续腹腔引流及行腹腔内灌注化疗。
Methods: the continuous intraperitoneal drainage by central venous catheter and intraperitoneal perfusion of chemotherapeutic drugs were applied to 9 patients with carcinomatous ascites.
结论：在中晚期消化道肿瘤，尤其伴有腹水病人治疗中，采用持续腹腔热灌注化疗可明显提高治疗效果。
Conclusions: CHPP on patients with late digestive tract cancer, especially those patients followed by ascites, can evidently enhance the effectiveness of the treatment.
目的：观察腹腔热灌注化疗联合热疗治疗恶性腹水的疗效及其副反应。
Objective: To evaluate the effects and toxicities of the chemotherapeutic hyperthermic intraperitoneal perfusion(CHIP) combined with hyperthermia for the treatment of malignant ascites.
结论：应用康莱特联合顺铂热灌注化疗治疗恶性腹腔积液有一定的效果，值得推广应用。
Conclusion: the application of perfusion chemotherapy of kang-lai-te injection with cisplatin for malignant ascites. has a certain effect and should be widely applied.
目的探讨HGGZ-102型体腔热灌注治疗机对犬腹腔热灌注化疗的安全性。
Objective The present study is to explore the safe of chemotherapeutic hyperthermic intraperitoneal perfusion by using the HGGZ-102 hyperthermic perfusion machine.
方法对146例进展期胃癌病人分组行腹腔热低渗液灌注及动脉插管化疗，并对其腹腔转移率、肝转移率及3年生存率对照研究。
Methods 146 patients were divided into treated and control group. The peritoneal and hepatic recurrence and 3 year survival rate of each group were analyzed.
方法对146例进展期胃癌病人分组行腹腔热低渗液灌注及动脉插管化疗，并对其腹腔转移率、肝转移率及3年生存率对照研究。
Methods 146 patients were divided into treated and control group. The peritoneal and hepatic recurrence and 3 year survival rate of each group were analyzed.
应用推荐